Human small intestine samples and maintenance media

The U.S. Food and Drug Administration is forecasting a future procurement for human small intestine samples and associated maintenance media to support the development and use of reconstructed human intestine models. This effort is intended to advance scientific research, likely for drug safety, toxicity testing, or physiological studies, leveraging biologically accurate human tissue models to improve predictive outcomes over animal or synthetic alternatives. The solicitation is classified under NAICS code 541990, indicating it falls under other scientific research and development services, and the work is expected to be performed by a contractor capable of providing high-quality, ethically sourced human intestinal tissue maintained under controlled, physiologically relevant conditions. The point of contact for program inquiries is the NCTR Acquisition Liaison, reachable via nctracquisitions@fda.hhs.gov, while the contracting officer position has not yet been filled. There is no specified set-aside designation, meaning the opportunity is open to all eligible businesses regardless of size or status. The anticipated posting date is May 25, 2026, and interested parties should monitor the official HHS OSDBU portal for the formal solicitation. The exact location of performance has not been designated, suggesting flexibility or that work may occur at multiple qualified facilities meeting FDA standards for tissue handling and research integrity.